RESISTANCE DATA

ZERO PATIENTS DEVELOPED PI RESISTANCE
THROUGH 144 WEEKS1

Atazanavir showed a high genetic barrier to resistance regardless of booster in Study 1141

Patients Developing Resistance Through Week 144

Patients Developing Resistance
Through Week 144

infographic of PI resistance through week 48 infographic of PI resistance through week 48

r=ritonavir; PI=protease inhibitor; TDF=tenofovir disoproxil fumarate; FTC=emtricitabine.

  • 21 patients in the EVOTAZ arm and 19 patients in the REYATAZ/r arm met criteria for resistance testing and had data available1
  • Resistance to atazanavir may not preclude the subsequent use of other PIs2

Resistance profile is an important factor in preserving future treatment options